|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:administeredBy
|
gptkb:physician
|
|
gptkbp:approvalYear
|
2008
|
|
gptkbp:approvedBy
|
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:ATCCode
|
L04AB05
|
|
gptkbp:CASNumber
|
877399-52-5
|
|
gptkbp:contraindication
|
tuberculosis
active severe infections
|
|
gptkbp:developer
|
gptkb:UCB
|
|
gptkbp:form
|
prefilled syringe
lyophilized powder
|
|
gptkbp:genericName
|
gptkb:certolizumab_pegol
|
|
gptkbp:halfLife
|
14 days
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cimzia
|
|
gptkbp:KEGGID
|
D08913
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
TNF inhibitor
|
|
gptkbp:MedlinePlusID
|
a608007
|
|
gptkbp:monoclonalAntibodyType
|
gptkb:Fab_fragment
|
|
gptkbp:pegylated
|
true
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:prescribes
|
adults
sometimes for pregnant women with certain conditions
|
|
gptkbp:PubChem_CID
|
CHEMBL1201836
DB08904
|
|
gptkbp:routeOfAdministration
|
subcutaneous injection
|
|
gptkbp:sideEffect
|
nausea
headache
infections
injection site reactions
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:UNII
|
81Y730J8YY
|
|
gptkbp:usedFor
|
gptkb:Crohn's_disease
gptkb:psoriatic_arthritis
rheumatoid arthritis
ankylosing spondylitis
non-radiographic axial spondyloarthritis
|
|
gptkbp:bfsParent
|
gptkb:UCB_Biopharma
gptkb:UCB_Pharma
|
|
gptkbp:bfsLayer
|
7
|